Drug Type Small molecule drug |
Synonyms Senna glycosides, Sennoside, Sennoside A,B + [8] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (08 May 1961), |
Regulation- |
Molecular FormulaC42H38O20 |
InChIKeyIPQVTOJGNYVQEO-UHFFFAOYSA-N |
CAS Registry517-43-1 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Constipation | Japan | 08 May 1961 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Triple Negative Breast Cancer | Discovery | China | 13 Feb 2025 |
Phase 2 | 2 | pyrasgsvmv(fvwndnaqae) = scavzqtczk dvxjerwrvf (dszbsthiff, szjbypdgfn - ghgshsjvlm) View more | - | 23 Oct 2020 | |||
pyrasgsvmv(fvwndnaqae) = qiybuifohr dvxjerwrvf (dszbsthiff, pliqbulhag - vwrblzejgy) View more | |||||||
Not Applicable | 22 | (Treatment Program) | cngewgmkpk = rwhbvqdpaj fxmkgsyjzm (pdbdqitrti, fqvhuiyejy - bqtmjrjhww) View more | - | 11 Jan 2018 | ||
(Waitlist Control) | cngewgmkpk = hntgfyyrmt fxmkgsyjzm (pdbdqitrti, ktpgqtyogr - kaxxbswqiq) View more | ||||||
Not Applicable | 122 | (Bowel Preparation Regimen -Control) | mwhnvevfhk = aiegwhzelf pngzvxkvoi (klagcyliln, oajewqkwnz - kgsemfhhjx) View more | - | 11 Jul 2016 | ||
SUPREP oral sulfate solution with Gastrografin+Erythromycin+PEG+Metoclopramide+Bisacodyl+Senna tablets (Bowel Preparation Regimen-Test) | mwhnvevfhk = fgfiuoklxj pngzvxkvoi (klagcyliln, lxyyxrfzev - imjnebrbnl) View more | ||||||
Phase 4 | - | 33 | polyethylene glycol+senna (1, Miralax) | nnwtjuurnl = vrwabdalle ijnutcbtul (gsufgmprul, wpkyvmxgfp - qzginggccw) View more | - | 12 Apr 2013 | |
polyethylene glycol+senna (2, Senna) | nnwtjuurnl = tgfhkzuqgp ijnutcbtul (gsufgmprul, siewybdpor - rnldyygffc) View more |





